Website
N/ATelephone
61.13.0045.3688
Address
1868-1892 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.47 - 3.87
Trade Value (12mth)
AU$450,394.00
1 week
1.91%
1 month
0.38%
YTD
-8.25%
1 year
-17.34%
All time high
6.39
EPS 3 yr Growth
-12.200%
EBITDA Margin
25.80%
Operating Cashflow
$144m
Free Cash Flow Return
36.50%
ROIC
9.10%
Interest Coverage
12.90
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
201m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
6.52
Date | Announcements |
---|---|
31 October 23 |
Becoming a substantial holder from AEF
×
Becoming a substantial holder from AEF |
29 March 23 |
TOV: HLS Panel Receives Application
×
TOV: HLS Panel Receives Application |
29 March 23 |
Change in substantial holding
×
Change in substantial holding |
29 March 23 |
Change in substantial holding
×
Change in substantial holding |
28 March 23 |
Update - Dividend/Distribution - ACL
×
Update - Dividend/Distribution - ACL |
28 February 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 August 23 |
Becoming a substantial holder
×
Becoming a substantial holder |
28 April 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 April 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 April 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 September 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 October 22 |
Medlab Pathology Cyber Incident
×
Medlab Pathology Cyber Incident |
27 March 23 |
HLS: Directors' Statement re Takeover
×
HLS: Directors' Statement re Takeover |
27 March 23 |
Suspension of DRP
×
Suspension of DRP |
27 March 23 |
Becoming a substantial holder
×
Becoming a substantial holder |
26 August 22 |
Change in substantial holding
×
Change in substantial holding |
26 August 21 |
FY21 financial results investor presentation
×
FY21 financial results investor presentation |
24 September 21 |
Annual Report to shareholders
×
Annual Report to shareholders |
24 September 21 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
24 February 22 |
Appendix 4D
×
Appendix 4D |
24 February 22 |
Media Release - 1H22 Financial Results
×
Media Release - 1H22 Financial Results |
24 February 22 |
1H22 Investor Presentation
×
1H22 Investor Presentation |
24 February 22 |
Dividend/Distribution - ACL
×
Dividend/Distribution - ACL |
24 February 22 |
Establishment of Dividend Reinvestment Plan
×
Establishment of Dividend Reinvestment Plan |
23 October 23 |
2023 AGM - Chair and CEO Address
×
2023 AGM - Chair and CEO Address |
23 October 23 |
2023 AGM results
×
2023 AGM results |
23 May 23 |
HLS: Directors' Statement re Takeover
×
HLS: Directors' Statement re Takeover |
23 May 22 |
Presentation to ASA Conference
×
Presentation to ASA Conference |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.